Froncort.AI
For Biopharma companies with expensive R&D processes and low success rates, our tool reduces R&D cost/effort by 95% and improves regulatory effectiveness.
- Stage Prototype Ready
- Industry Artificial Intelligence
- Location Glastonbury, CT, USA
- Currency USD
- Founded August 2022
- Employees 3
- Incorporation Type C-corp
- Website froncort.ai
Company Summary
Froncort® is a team of domain experts with 120+ years of combined inter-disciplinary healthcare, research, and technology experience. We present a revolutionary Platform based on proprietary Evidence Synthesis methodology that automates rcomplex R&D workflows and can be leveraged for regulatory submissions for Pharmaceuticals, Biologics, and In-Vitro Diagnostics (IVD), enabling a 95% cost and time reduction.
Team
-
CEO -
Ujjwal RaoChief Medical Officer
Advisors
-
John VaraklisUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.